Gabbard's Biolab Declassification — What Was Actually Revealed – Good Machine

TL;DR

Outgoing DNI Tulsi Gabbard released declassified documents on Friday confirming US taxpayer funding of more than 120 biological laboratories across 30-plus countries, with roughly one-third in Ukraine.
The documents name specific pathogens stored at these facilities — anthrax, Ebola, Marburg, plague — and flag biosafety deficiencies at several sites, particularly in Kharkiv.
Gabbard accused the Biden administration, Anthony Fauci, and national security officials of having "lied" about the labs' existence and "threatened those who attempted to expose the truth."
Independent experts immediately pushed back: the labs were never secret, the Cooperative Threat Reduction Program has been publicly documented since 2005, and the work is defensive — dismantling Soviet bioweapons infrastructure, not building new ones.
The release is best understood as an act of political theatre with real-world consequences: it revives a Russian propaganda narrative, complicates US biosecurity cooperation, and demonstrates how declassification authority can be wielded as a weapon on the way out the door.

What Happened

On Friday 12 June, Director of National Intelligence Tulsi Gabbard — who will leave her post on 19 June — released a set of partially redacted declassified documents detailing US government funding for biological laboratories in more than 30 countries. The release came via the Office of the Director of National Intelligence (ODNI), accompanied by a press statement and a slide deck.

The core claims in the release:

More than 120 labs received US taxpayer funding.
Roughly one-third are located in Ukraine, putting them at risk of "compromise" amid Russia's ongoing war.
Pathogens stored or studied at these facilities include anthrax, tularemia, tuberculosis, swine fever, MERS, SARS, Marburg, Ebola, Lassa, plague, and rickettsia.
Some labs conducted "dangerous Gain-of-Function research" with "very little visibility or oversight."
Four labs alone cost taxpayers more than $9 million.
The Biden administration "lied" about the labs' existence and threatened whistleblowers.

Gabbard's language was unusually direct for an intelligence chief: "Politicians, so-called health professionals like Dr. Fauci, and entities within the Biden administration's national security team lied to the American people about the existence of U. S.-funded and supported biolabs."

The documents were declassified in April, according to Newsweek, but held until Friday — five days before Gabbard's departure.

What It Actually Means

The story here is not what was revealed. It is the gap between what was revealed and how it was framed.

The labs were never secret. The Cooperative Threat Reduction (CTR) Program — also known as the Nunn-Lugar program — has been publicly documented since the 1990s. It was created by a bipartisan act of Congress to help former Soviet states secure and dismantle weapons of mass destruction after the USSR collapsed. The biological component, the Biological Threat Reduction Program (BTRP), has invested approximately $200 million in Ukraine since 2005, supporting 46 laboratories, health facilities, and diagnostic sites. The Department of Defense has published fact sheets. Congress has held oversight hearings. Ukraine has submitted 27 Confidence Building Measures to the Biological Weapons Convention — publicly posted.

The DoD's own 2022 fact sheet states plainly: "DoD's CTR Program began its biological work with Ukraine to reduce the risk posed by the former Soviet Union's illegal biological weapons program, which left Soviet successor states with unsecured biological materials after the fall of the USSR."

This is not a secret programme that was exposed. It is a long-standing, publicly acknowledged programme that was reframed as a secret programme.

The cover-up claim is the real payload. Gabbard's accusation that the Biden administration "lied" rests on a specific sequence: in March 2022, Undersecretary of State Victoria Nuland testified that "Ukraine has biological research facilities which, in fact, we are now quite concerned Russian troops, Russian forces, may be seeking to gain control of." The following day, other administration officials walked that back. ODNI now characterises that walk-back as part of an "Information Resilience" strategy designed to "shape the public narrative" and "mitigate and counter foreign malign influence."

In other words: the Biden administration acknowledged the labs when it was strategically convenient (to warn about Russian seizure risk) and downplayed them when it was politically inconvenient (to avoid feeding Russian propaganda). That is a story about messaging discipline, not a story about secret bioweapons. But Gabbard's framing collapses that distinction.

The documents don't show what the rhetoric implies. As Newsweek noted in its careful analysis, the slides "do not provide direct evidence that the facilities are engaged in offensive biological weapons development, even as they reference allegations to that effect." The briefing "stops short of substantiating more serious claims about illicit weapons activity."

What the documents do show — US-funded labs handling dangerous pathogens in a war zone with documented biosafety deficiencies — is genuinely concerning. But it is concerning in the way that any biosafety-level-3 facility in an active conflict zone is concerning. It is not evidence of a secret bioweapons programme.

The Quieter Story

Josh Segal, a biological weapons expert who served with American arms control delegations and on the UN special commission on Iraq's bioweapons programme, told the New York Post: "I am really confused as to why the DNI released something giving new life to a misleading narrative the entire intel community has known for decades to be a Russian trope and that the Trump administration worked hard to crush in its first term."

He added: "Their labs are not now and were never secret, and do zero questionable work."

Segal also noted that the CTR programme "was responsible for destroying 12 tons of weaponized anthrax the Russians abandoned on Resurrection Island in the Aral Sea."

This is the paradox at the centre of the story: the programme Gabbard's release frames as a dangerous secret was, in fact, a programme designed to eliminate dangerous secrets — the Soviet Union's abandoned bioweapons infrastructure.

Hype Deconstruction

Three things are being conflated here, and separating them is essential:

The existence of US-funded biolabs abroad. This is real, long-documented, and not controversial among people who follow biosecurity. The CTR programme has been operating for decades with bipartisan support.
The claim that these labs were "covered up." This is partially true in a narrow sense — the Biden administration was inconsistent in its public messaging, at times acknowledging the labs and at times downplaying them. But the claim that their very existence was denied is contradicted by the public record.
The implication that these labs represent a secret bioweapons programme. This is not supported by the declassified documents themselves. It is, however, precisely the narrative Russia has pushed since at least 2022, when it cited alleged US biolabs in Ukraine as partial justification for its invasion.

The release is being covered as an "exposure" of a hidden programme. It is more accurately described as the declassification of documents about a public programme, framed inside an accusation of cover-up, released by an outgoing official with a well-documented history of scepticism toward the intelligence establishment she was briefly tasked with leading.

Stakeholder Landscape

Who benefits from this being in the news:

Russia. The release directly revives a Russian propaganda narrative that the US is operating secret bioweapons labs near Russia's borders. Moscow has been pushing this line since 2022. Gabbard's release — from the office of the DNI, no less — gives it a credibility boost no Russian information operation could achieve on its own.
Gabbard herself. The release positions her as a truth-teller taking on a corrupt establishment on her way out. It is a political identity play as much as an intelligence disclosure.
Republican critics of the biosecurity establishment. The release provides ammunition for those who have long argued that gain-of-function research and biolab oversight are dangerously opaque.

Who is directly affected:

US biosecurity cooperation partners. Countries hosting CTR-supported labs now face renewed scrutiny and potential political backlash. Future cooperation may become harder to sustain.
Ukrainian scientists and public health officials. The labs in question do real diagnostic and surveillance work. Framing them as secret bioweapons facilities endangers the people who work there and the work they do.
The incoming DNI. Trump's nominee Jay Clayton will inherit whatever diplomatic and institutional fallout this release generates.

Who is not affected despite the noise:

The average American. The biosafety risks flagged in the documents are real but remote. The release does not change the practical threat landscape for US citizens.

Cross-Layer Implications

Geopolitical. The release hands Moscow a propaganda victory at a delicate moment. The Trump administration is simultaneously negotiating with Iran and managing the Ukraine conflict. Reviving the biolabs narrative complicates both tracks by reinforcing Russian claims about US malfeasance.

Institutional. This is a case study in how declassification authority can be weaponised. A departing DNI used her final days to release selectively framed documents that serve a political narrative. The intelligence community's norms around declassification — designed to prevent exactly this kind of politicisation — appear to have been bypassed.

Biosecurity. The practical effect may be to make international biosecurity cooperation harder. If partner nations fear that US-funded labs will be politically weaponised by future administrations, they may become more reluctant to host them. That would be a genuine loss for global health security.

Precedent. Gabbard's release, combined with her simultaneous rescission of Biden-era Havana Syndrome assessments (which her office said "selectively excluded relevant intelligence" and "suppressed alternative analysis"), establishes a template: outgoing officials can use their final days to reshape the intelligence record in ways that serve their political alignment.

What This Means for You

For the general reader, the honest answer is that there is little actionable here. The biolabs exist. They have existed for decades. They handle dangerous things. Some of them are in war zones. These are facts worth knowing, but they do not change the risk calculus for any individual.

For those who follow geopolitics and intelligence: watch what happens to the CTR programme in the next budget cycle. If this release triggers congressional scrutiny that leads to funding cuts, the real-world consequence will be less biosecurity cooperation, not more. That would be an ironic outcome for a release framed around safety.

For journalists and analysts: the lesson here is about framing. When a declassification is accompanied by an accusation of cover-up, the accusation becomes the story — even when the documents don't support it. The gap between what the documents show and what the press release claims is the real subject. Cover that gap.

Uncertainty Ledger

What pathogens are currently stored at which facilities? The documents are partially redacted and provide only high-level summaries. The current status of pathogen collections at Ukrainian labs — many of which were reportedly destroyed or relocated after Russia's 2022 invasion — is unclear.
What does "gain-of-function research" mean in this context? The term is used in the ODNI release but not defined. Gain-of-function research spans a wide spectrum, from legitimate vaccine development to experiments that genuinely increase pathogen transmissibility. Without specificity, the label does more rhetorical work than analytical work.
Will the incoming DNI continue or reverse Gabbard's transparency push? Jay Clayton's views on biosecurity transparency are unknown. The programme Gabbard initiated — "to identify where these labs are, what pathogens they contain" — could continue, stall, or be reversed.
What was actually redacted? The documents remain partially classified. The redactions may contain information that would either strengthen or weaken Gabbard's narrative. We don't know.

Bottom Line

Tulsi Gabbard's final act as DNI was to declassify documents confirming something that was never classified: the United States funds biological laboratories abroad as part of a decades-old programme to secure dangerous pathogens and prevent pandemics. She framed this as an exposure of a cover-up. The documents show a public health and biosecurity programme — one with real vulnerabilities, especially in wartime Ukraine — but they do not show the secret bioweapons enterprise the rhetoric implies. The release matters not because it revealed something new, but because it demonstrated how effectively declassification can be repurposed as a political instrument. The real beneficiary is Moscow, which has been pushing this exact narrative since 2022 and just received an endorsement from the office of the US Director of National Intelligence.

Sources:

New York Post, "Outgoing DNI Tulsi Gabbard releases declassified info on 120 foreign biolabs," 12 June 2026. (Tier 1)
Newsweek, "Tulsi Gabbard Reveals Declassified Map, Records of Ukraine Bio Labs," 12 June 2026. (Tier 2)
CNN, "Gabbard rescinds Biden-era intel assessments that were skeptical about 'Havana Syndrome,'" 12 June 2026. (Tier 1)
US Department of Defense, "Biological Threat Reduction Program Activities in Ukraine," Fact Sheet, March 2022. (Tier 1 — primary document)
Congressional Research Service / DTRA, "Biological Security Engagement in Ukraine," factsheet. (Tier 1 — primary document)
The Guardian, "Trump news at a glance: sidelined Tulsi Gabbard resigns," 23 May 2026. (Tier 1)
Politico, "Tulsi Gabbard out as DNI," 22 May 2026. (Tier 1)
Forbes, "Tulsi Gabbard Resigns As Director Of National Intelligence," 22 May 2026. (Tier 2)
Washington Post, "Tulsi Gabbard resigns as director of national intelligence," 22 May 2026. (Tier 1)
ODNI declassified slide deck, dni.gov/files/BIOLAB_Slides.pdf. (Tier 1 — primary document)